%0 Journal Article
%T Pediatric Aggressive Mature B-Cell Lymphomas, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.
%A Davies K
%A Barth M
%A Armenian S
%A Audino AN
%A Barnette P
%A Cuglievan B
%A Ding H
%A Ford JB
%A Galardy PJ
%A Gardner R
%A Hanna R
%A Hayashi R
%A Kovach AE
%A Machnitz AJ
%A Maloney KW
%A Marks L
%A Page K
%A Reilly AF
%A Weinstein JL
%A Xavier AC
%A McMillian NR
%A Freedman-Cass DA
%J J Natl Compr Canc Netw
%V 18
%N 8
%D 08 2020
%M 32755986
%F 12.693
%R 10.6004/jnccn.2020.0036
%X Pediatric aggressive mature B-cell lymphomas are the most common types of non-Hodgkin lymphoma in children, and they include Burkitt lymphoma (BL) and diffuse large B-cell lymphoma (DLBCL). These diseases are highly aggressive but curable, the treatment is complex, and patients may have many complicated supportive care issues. The NCCN Guidelines for Pediatric Aggressive Mature B-Cell Lymphomas provide guidance regarding pathology and diagnosis, staging, initial treatment, disease reassessment, surveillance, therapy for relapsed/refractory disease, and supportive care for clinicians who treat sporadic pediatric BL and DLBCL.